Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm not sure what kind of companies you are doing deals with but reputable companies don't do business that way. Dr. Seymour does not do business that way. You can speculate all you want, in fact anybody can say anything here, but I would suggest sticking to factual information in evaluating one's stock investment.
Seaside is a private investment partnership that gets its money FROM institutional (and retail) investors. So I'm thinking not reportable as institutional in the usual sense but somebody else might have more insight into this.
you could be right.
I wouldn't bother him with something so trivial. It is quite possible that buyers of the stock just shy away when the overhang is out there.
Private investors, per the press release:
You really think Diwan stopped selling because people on this forum were complaining?
they are running a business, they don't care about short term moves in the stock price.
Yes, they had 18 mos of cash, now they have 24 months. They are looking ahead to secure future financing requirements so there are no hiccups during the most critical phase in the development of the company.
The forced selling by Diwan started in June, hard to use the pattern "since June" as any significant indicator.
It is clear that there are several here who feign being long but would obviously like to see the stock lower.
from Oct 17th press release,
when exactly would you expect them to be in clinical trials? Your "research" is a tad deficient.
the stock is working through a sell order of 55,000 shares, first at .99, then lowered to .985. There are 24,000 shares left on that order.
??? DRACO is a good 5 yrs behind NNVC. Do a little research.
DRACO is yrs behind NNVC. They won't be competition any time soon.
The production lab funding is taken care of.
certainly by Wed. Probably AM.
AABA conspicuously absent.
I think they would generally be more receptive to someone like you that appears to be involved with the healthcare industry. In any case, I certainly don't have the time to pursue it. Though based on the response you got it could prove a very worthwhile endeavor.
I am quite surprised they were that open minded and receptive. Perhaps the same letter to all the majors?
I am also quite surprised that a company of the size and resources of Pfizer had no knowledge of what NNVC is doing.
Big pharma's pipelines are running thin. New drug discoveries are becoming more and more difficult and costly at the same time many big name drugs are coming off patent. They should certainly be motivated to look at some of the emerging opportunities.
yes, and it is possible you could be hit by a meteor tomorrow morning.
If Dr. Seymour is saying he has an idea on when the call will be made I would bet it would be fairly soon.
There are a number of reasons why you cannot compare these 2 companies. For starters, do you have any idea how long it takes to do cancer clinicals? Which would you rather have, a drug for cancer in a very competitive field or a platform that has the potential to eradicate all major viruses?
the stock will be much higher on the eve of clinical trials.
they may not yet have all the data back, but all the animal testing for Flucide has been completed. That looked like old language that is in need of revision.
No, Diwan stopped selling because they found some outside private investors as stated in the press release.
None of the order I saw got filled. As soon as it came on the offer quickly bumped up to .925.
55,000 share bid at .89 popped up at the tail end of the day. Not filled. Probably scared the MM's into raising the offer to .925
AABA...they are controlling both sides of it.
Your math is bogus. If the stock starts at $1 and eventually goes to $50, do you really care the route it takes to get there? You don't get diluted just because a stock temporarily dips. This is a long term wealth building opportunity, traders can dart in and out at their own peril.
Boy, this just gets silly. Diwan still has over 6 million shares, do you really think his interests don't align with stock holders? Thankfully, Seymour and Diwan have the long term interests of the company at heart, not short term stock moves. They're building their manufacturing facility without issuing any stock which means NO stockholder dilution. And also without depleting precious cash from the treasury. They are doing it this way because, regardless of temporary stock weakness, it is in the best interest of the company. Take advantage of the forced selling. Even though you are suffering a short term setback, your shares will be worth more in the long run because they decided not to dilute. Let them run their company, the stock price will take care of itself. Just maybe not on your timetable.
Puff
If in fact they have a cure for the flu, as it does seem they do, does a few months here or there really matter? This board is incredibly myopic. A scourge of thousands of yrs and death of untold millions about to be eliminated by a simple injection. Trading at a market cap of only $122M, what a phenomenal opportunity. This stock has to be the best risk/reward investment out there. And that doesn't inlcude all the other major drug candidates in their pipeline. All the whining tells me we are very near, if not at, the bottom. Either you trust management or you don't. If you don't, you should have been out long ago. Cheers,
Puff Daddy
yes, I think necessarily so. I probably would not plan on it being in there, but I don't think it matters much unless you are a day trader.
?? No, Diwan has only about half of the original 2 million shares left to sell. Approx 1M shares have been sold and about another 1 million left to go.
This was just posted on another forum. The question to Dr. Seymour was whether the 10-K filing was delayed for potential pre-IND application submission to be included in the report.
Wouldn't the delay in filing the 10K be so that they can include the pre-IND filing in the report?
Much of that uncertainty is already reflected in a $1.25 or so share price.
No, he will try to meter it out, but it will provide steady pressure for a little while. He's already got a pretty good jump on it as evidenced in the recent Form 4 filings. The faster he sells, the more shares he will have to sell to reach his target. Traders pile on ahead of it. But traders could get caught with some hard snapbacks.